Sensitivity, Tooth
Conditions
Brief summary
To assess the impact of the use of 5% Calcium Sodium Phosphosilicate or 8% Arginine dentifrices on dentinal hypersensitivity following non-surgical periodontal therapy in patients with periodontitis.
Detailed description
To assess the impact of the use of 5% Calcium Sodium Phosphosilicate or 8% Arginine dentifrices on dentinal hypersensitivity following non-surgical periodontal therapy in patients with periodontitis. patients will be selected on the bases of inclusion and exclusion criteria.Descriptive statistics will be presented for both qualitative and quantitative variables
Interventions
DRUG5% CALCIUM SODIUM PHOSPHOSILICATE
Calcium sodium phosphosilicate is a particulate, bioactive glass material that degrades in the aqueous oral environment to release calcium and phosphate ions, leading to formation of hydroxycarbonate apatite on the dentine surface result in reduction in dentine hypersenstivity
DRUG8% Arginine
Arginine contributes to Whole Mouth Health. It also plays a role with respect to dental caries, helping to maintain a pH-neutral environment, and is proven to rapidly help relieve dentin sensitivity. Arginine is truly a remarkable ingredient now being used in oral care products.
Sponsors
Armed Forces Institute of Dentistry, Pakistan
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
30 Years to 65 Years
Healthy volunteers
Yes
Inclusion criteria
1. Participants must be between 30 and 65 years old. 2. Participants should be in good general health. 3. Participants must have a diagnosis of generalized chronic periodontitis according to the 1999 classification definition. 4. Participants should complain of at least two teeth with dentinal hypersensitivity. 5. Participants must exhibit moderate to severe dentinal hypersensitivity (Schiff's scores of 2 to 3) or tactile stimulation (Visual Analogue Scale (VAS) score \>4) after at least one scaling and root planing session.
Exclusion criteria
1. Individuals with dentinal hypersensitivity symptoms prior to periodontal treatment. 2. Those who have used agents to treat hypersensitivity in the past 3 months. 3. Participants who are allergic to the test products (5% CSPS or 8% arginine). 4. Dentinal hypersensitivity caused by factors such as dental caries, defective restorations, fractured teeth, abrasion or abfraction, extensively restored teeth, or restorations extending into the test area. 5. Individuals who have undergone orthodontic treatment within the past 3 months. 6. Patients with crowded teeth or serving as abutment teeth for fixed or removable prostheses are also excluded from the study.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| To assess the impact on Dentinal hypersensitivity following the use of 5% CSPS or 8% Arginine following non-surgical periodontal therapy in patients with Periodontitis by VAS. | within 8 weeks from the start of procedure | Define pain and discomfort via running a probe on dentine of tooth The most simple VAS is a straight horizontal line of fixed length, usually 100 mm. The ends are defined as the extreme limits of the parameter to be measured (symptom, pain, health) orientated from the left (worst) to the right (best). In some studies, horizontal scales are orientated from right to left. |
| To assess the impact on Dentinal hypersensitivity following the use of 5% CSPS or 8% Arginine following non-surgical periodontal therapy in patients with Periodontitis by Schiff scale. | within 8 weeks from the start of procedure | Schiff Cold Air Sensitivity Scale: is a tool used to assess dentinal hypersensitivity (DH) or tooth sensitivity to cold air. It's a clinical method developed to quantify the severity of cold air sensitivity experienced by individuals with dentin hypersensitivity. The scale typically ranges from 0 to 3, with the following descriptions: 0: No response to cold air 1. Mild, brief, or localized response to cold air 2. Moderate response to cold air, patient can tolerate 3. Severe and prolonged response to cold air, patient finds it intolerable |
Countries
Pakistan
Contacts
Primary ContactMuhammad J Iqbal, BDS
Outcome results
None listed